IRCT20210726051995N1招募中3 期
Acetylcysteine for the Prevention of Liver Injury in Covid-19 Intensive Care Unit Patients Under Treatment with Remdisivir: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
Artesh University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Diagnosed positive for Covid-19 based on PCR testing
- •Admitted in intensive care unit
- •Treated with remdesivir
排除标准
- •Positive history of any underlying liver disease e.g. fatty liver, or acute or chronic hepaptitis
- •Plasma levels of liver transaminases over 100 IU/L on the first day of ICU admission
- •Simultaneous use of any hepatotoxic drugs
研究者
相似试验
已完成
不适用
se of N-Acetylcysteine for prevention of Heart-Lung machine associated liver complication in cardiac surgeryCTRI/2018/05/014024Dr Ram Manohar Lohia institute of Medical Sciences Lucknow66
已完成
不适用
acetylcysteine as a Preventive Measure for Contrast Induced Nephropathy in Intensive Care Patients with Renal InsufficiencyRenal insufficiencyUrological and Genital DiseasesISRCTN43635237Academic Medical Centre (AMC) (Netherlands)246
已完成
2 期
A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary BypassHeart DiseaseRenal InsufficiencyNCT00187330Sunnybrook Health Sciences Centre104
进行中（未招募）
不适用
Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARApatient with ST elevation myocardial acute infarctionMedDRA version: 9.1Level: SOCClassification code 10007541EUCTR2010-022952-22-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
已完成
2 期
The effect of N-acetyl L-cysteine in Chronic obstructive pulmonary diseaseIRCT201509064345N5Vice chancellor for research of Guilan University of Medical Sciences60